A r t i c l e s
Isoform 1 is expressed only in the testes and brain, whereas isoform 2 is expressed in the brain, testes, heart and mammary glands ( Supplementary Fig. 1b) .
To investigate the physiological and developmental roles of miR-212 and miR-132 in mice, we used homologous recombination to delete the genomic region that encodes pre-miR-212 and pre-miR-132 ( Supplementary Fig. 2a ). DNA blotting (Supplementary Fig. 2b ) and quantitative RT-PCR analyses (data not shown) confirmed successful genomic deletion and the complete loss of both microRNAs in homozygous mutants.
miR-212/132 −/− mice were born with the expected Mendelian ratio and had a normal life span. However, although the female miR-212/132 −/− mice showed normal nursing behaviors, their pups had severe growth problems (Fig. 1a) and usually died within 5 days of birth. The survival rate of these pups was inversely proportional to the litter size (data not shown). Cross-fostering experiments showed that wild-type females' pups faced the same problems under the care of miR-212/132 −/− mothers, whereas the pups of miR-212/132 −/− females grew and survived normally if they were fostered by wild-type mothers (data not shown). Thus, miR-212/132 −/− female mice had difficulty in feeding their pups.
To identify the reason for this difficulty, we examined lactating mammary glands histologically (Fig. 1b) . In contrast to wild-type or heterozygous glands, miR-212/132 −/− glands had an abnormal appearance. Dense lobuloalveolar structures were restricted to the regions close to the nipple area, and the rest of the fat pads had no epithelial structures.
Impaired ductal outgrowth in miR-212/132 −/− glands
We characterized the observed phenotype further by whole-mount staining of the mammary glands of pubertal, pregnant and lactating mice ( Fig. 2 and Supplementary Fig. 3 ). The rudimental ductal trees appeared normal in both wild-type and miR-212/132 −/− pre-pubertal mice (Fig. 2a,b) . At 5 weeks of age, the ductal structures reached the region of the lymph nodes in wild type glands and TEBs were visible at their distal ends (Fig. 2c) . However, the rudimental ductal trees in . Lactating samples (i,j) were obtained from mice killed 1 day after giving birth. Proximal-to-distal orientations of all samples are shown as left-to-right. The grayscale insets are highmagnification pictures of corresponding samples for detailed visualization. In wild-type glands, TEBs were formed (arrow in c) and ductal outgrowth took place during puberty (c,e). No TEBs were observed at the distal ends of the ducts in mutant glands (arrowhead in d) and ductal outgrowth did not take place (d,f). Ductal side branching was observed in mutant glands (arrows in h) similar to wild-type glands (g). Lobuloalveolar structures were formed in mutant glands during pregnancy and milk-producing alveoli were seen during lactation (j) similar to wildtype glands (i), but restricted to the proximal region where the rudimentary ductal tree was located. At least five mice were analyzed for each genotype at each stage. Scale bars represent 1 cm; for grayscale insets, scale bars represent 1 mm. (Fig. 2d) . At 10 weeks of age, the ductal tree in wild type littermates almost reached the end of the fat pad (Fig. 2e) , but the ductal structures in mutant glands retained their pre-pubertal appearance (Fig. 2f) . Wild-type glands contained elaborate epithelial structures at 40 weeks of age owing to extensive ductal side-branching that had occurred during repeated estrus cycles (Fig. 2g) . miR-212/132 −/− glands contained similar structures, although the ductal tree did not extend much further than in the pre-pubertal stage (Fig. 2h) .
The lobuloalveolar structures of mammary glands develop gradually during pregnancy and reach their mature forms by parturition (Fig. 2i) . Similar lobuloalveolar structures also develop in miR-212/132 −/− glands, but they extend through a much smaller portion (only up to 20%) of the fat pad ( Fig. 2j and Supplementary Fig. 3 ). Thoracic mammary glands showed similar phenotypes (data not shown). It seems reasonable that this difference accounts for the decrease in milk production and could explain the growth and survival problems of the pups of homozygous mutant females.
Mutant ducts lack TEB but retain the capacity for outgrowth
To determine whether there is a structural defect in miR-212/132 −/− epithelial ducts, we analyzed the pubertal mammary glands histologically. We found several typical TEB structures in wild-type glands but not in miR-212/132 −/− glands (data not shown). On the other hand, the ductal structures of both genotypes looked normal with an inner layer of luminal epithelium and an outer layer of myoepithelium (Fig. 3a,b) . Immunostaining for E-cadherin and cytokeratin-14 confirmed the identity of luminal epithelial (Fig. 3c,d ) and myoepithelial (Fig. 3e,f) cells, respectively. Both genotypes also had fibroblasts in the periductal stroma (Fig. 3a,b) .
Ductal outgrowth depends on extensive cellular proliferation of the cells in TEBs [12] [13] [14] . In addition, the lumen of growing ducts is generated through apoptosis of inner layers of body cells as the TEBs push the ductal outgrowth further 20 . As miR-212/132 −/− glands seem to contain no TEBs, we evaluated the numbers of apoptotic and proliferating cells only in the ductal regions of wild-type and miR-212/132 −/− glands. We found no significant difference in the number of TUNEL-or bromodeoxyuridine (BrdU)-positive cells (data not shown). This suggests that the observed phenotype is not due to a defect in proliferation or apoptosis in already formed ducts.
In miR-212/132 −/− mammary glands, the isometric growth of ducts continues during puberty (Supplementary Fig. 3 ), although the allometric growth driven by TEBs does not take place. Therefore, the main defect in miR-212/132 −/− glands should be related to the generation or stability of TEBs, or both. To find out whether the miR-212/132 −/− epithelia have an a priori defect in forming stable TEBs, we performed reciprocal mammary epithelial transplantation experiments.
We transplanted mammary epithelial ducts from pre-pubertal miR-212/132 −/− mice into cleared fat pads of pre-pubertal wild-type mice and vice versa (Fig. 4a) . When we transplanted pre-pubertal miR-212/132 −/− mammary epithelia into the cleared wild-type fat pad, they formed normal TEBs (arrows in Fig. 4b ) and invaded the whole fat pad (Fig. 4c,d) . Moreover, they also developed proper lobuloalveolar structures during pregnancy (Fig. 4e) . By contrast, pre-pubertal wild-type mammary epithelia that were transplanted into cleared fat pads from miR-212/132 −/− mice did not form TEBs (Fig. 4f) and consequently did not invade the mutant fat pads 12 weeks (Fig. 4g,h ) or 25 weeks after transplantation (data not shown). However, lobuloalveolar differentiation took place during pregnancy in the limited ductal regions around the transplantation site (Fig. 4i) at a similar level as in the non-transplanted contralateral gland of miR-212/132 −/− mice (data not shown).
These data suggest that the miR-212/132 −/− epithelia have no apparent histological defects or inherent functional deficiencies and can form TEBs to achieve normal ductal outgrowth. Our observation that wild-type epithelia show impaired ductal outgrowth in cleared miR-212/132 −/− fat pads also indicates that either the mammary stroma or the hormonal environment of miR-212/132 −/− mice is the primary cause of the impaired ductal outgrowth phenotype.
Mutant stroma is non-permissive for ductal outgrowth
From puberty, all subsequent stages of mammary gland development are under the control of endocrine systems [11] [12] [13] [14] . Estrogen and growth hormones are the main endocrine regulators of the pubertal stage of mammary gland development. Therefore, we measured the serum levels of both hormones in miR-212/132 −/− mice and found no significant differences when compared with female littermates of all genotypes ( Supplementary Fig. 4) .
As miR-212/132 −/− epithelia maintain the functional capacity to undergo ductal outgrowth, and estrogen and growth hormone levels are normal in the mutant mice, the impaired ductal outgrowth in mutant mammary glands is probably due to a stromal deficiency. To verify this hypothesis, we performed whole mammary gland transplantations.
We transplanted whole mammary glands from 5-week-old donor mice into 5-week-old wild-type and miR-212/132 −/− recipient mice (Fig. 5a ) or wild-type recipient mice ( Fig. 5b) , wild type or heterozygous glands contained proper TEBs and ductal outgrowth, which eventually covered the whole gland with epithelial ducts (Fig. 5c,d ). By contrast, miR-212/132 −/− glands showed no signs of ductal outgrowth when they were transplanted into either miR-212/132 −/− (Fig. 5e ) or wild-type mice ( Fig. 5f ).
To investigate the possibility that the mutant phenotype was caused by an earlier endocrine defect which might have an effect only during the onset of puberty, we also transplanted whole mammary glands from pre-pubertal mice into 5-week-old recipients and analyzed them 5 weeks later for the initiation of ductal outgrowth. Wild-type glands from pre-pubertal donors formed proper TEBs and showed normal ductal outgrowth in miR-212/132 −/− mice (Fig. 5g) . By contrast, we found no ductal outgrowths in glands that were transplanted from pre-pubertal miR-212/132 −/− donors into wild-type mice (Fig. 5h) . These findings clearly show that the cause of the mutant phenotype is not an endocrine defect, which could prevent the generation of TEBs during the onset of puberty.
Together, these results suggest that the cause of the impaired ductal outgrowth phenotype in miR-212/132 −/− mammary glands is that the mutant stroma is not permissive for pubertal outgrowth of epithelial ducts.
miR-212 and miR-132 are restricted to mammary gland stroma
We used quantitative RT-PCR to determine the expression kinetics of miR-212 and miR-132 during different stages of mammary gland development (Supplementary Fig. 5 ). Their expression is low at the pre-pubertal stage and gradually increases throughout puberty, reaching a maximum at around 10 weeks of age, which coincides with the completion of ductal outgrowth. Although the expression of miR-212 and miR-132 substantially decreases and reaches its minimum by the end of pregnancy, it starts to increase again immediately after parturition. High variability in expression during puberty and adulthood might indicate that the expression is controlled by the estrus cycle. Indeed, this variability is much lower before puberty and during pregnancy, when the estrus cycle is not activated or has been discontinued, respectively. The expression of miR-212 and miR-132 in periovulatory granulosa cells is highly upregulated after the induction of luteinizing hormone or human chorionic gonadotrophin 21 .
To determine which cell types in the mammary gland express miR-212 and miR-132, we isolated mammary epithelial organoids and stromal cells separately and checked the expression of their primary transcript (Supplementary Fig. 1b ) and mature forms (Fig. 6a) . The purity of isolated fractions was confirmed by quantitative RT-PCR results for vimentin and E-cadherin, which are cell markers for fibroblasts and luminal epithelium, respectively (Fig. 6b) . We also analyzed the expression of both microRNAs in the cleared fat pad, from which the epithelium was surgically removed at the pre-pubertal stage and analyzed 5 weeks after the operation. Our results show that cleared fat pad samples contained threefold more fibroblasts and about threefold higher expression of both miR-212 and miR-132 than did 10-week-old mammary gland samples (Fig. 6a) . Moreover, the expression of both microRNAs was detected in the mammary stromal cell fractions but not in the mammary epithelial organoids. Therefore, we conclude that miR-212 and miR-132 are expressed exclusively by the stromal cells in the mammary gland.
Structural defects in mutant periductal stroma
The mammary stroma comprises the fat pad and the periductal stroma. The fat pad contains mainly fibroblasts, preadipocytes, brown adipose tissue and white adipose tissue. The periductal stroma that surrounds the epithelial ducts is mainly composed of fibroblasts and collagen-rich ECM and is essential for the regulation of mammary gland development 16, 17 . As miR-212 and miR-132 were exclusively expressed in the mammary stroma and a stromal defect caused the impaired ductal outgrowth phenotype in miR-212/132 −/− glands, we investigated the integrity of the periductal stroma in mutant glands by Masson's trichrome staining.
The periductal stroma is rich in fibroblasts around the neck region of TEBs and in the distalmost ducts (Supplementary Fig. 6a,b) . In these regions, there are low levels of collagen. However, more proximal primary ducts are generally surrounded with collagen-rich periductal stroma but are associated with fewer fibroblasts (Supplementary  Fig. 6c ). We did not detect such collagen-rich periductal stroma around the proximal or relatively distal ducts of miR-212/132 −/− glands, although fibroblasts were still seen close to them (Supplementary Fig. 6d-f) . Mutant glands contained blue-staining mucus-like structures in almost every ductal lumen. In relatively distal ducts, it was mostly seen adjacent to the peripheries of the lumen, whereas it covered the lumen entirely in the more proximal ducts (Supplementary Fig. 6d-f) .
We also analyzed collagen deposition in transplanted glands composed of wild-type epithelia and miR-212/132 −/− stroma or vice versa (Supplementary Fig. 7) . Transplanted miR-212/132 −/− epithelia can form TEBs and undergo ductal outgrowth in the wild-type cleared fat pads (Fig. 4) . Mammary ducts formed in such transplants also had similar levels of collagen deposition to the non-transplanted contralateral glands (Supplementary Fig. 7a-c) . On the other hand, transplanted wild-type epithelia in mutant cleared fat pads showed impaired ductal outgrowth and also showed the same collagen deposition defect as observed in the non-transplanted contralateral glands (Supplementary Fig. 7d-f) . These results indicate that the collagen deposition defect in miR-212/132 −/− mammary glands is due to a defect not in the mutant epithelium, but in the mutant stroma.
miR-212 and miR-132 negatively regulate MMP-9 expression
The collagen in the periductal stroma of mammary glands is secreted mostly by the epithelia under the control of the tumour growth factor-β (TGF-β) pathway 22 . Collagen deposition is also regulated within the ECM by several matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs). MMPs that have a collagenase function degrade the collagen in the ECM, whereas TIMPs specifically inhibit the destructive functions of MMPs 23, 24 . In the mammary gland, these MMPs and TIMPs are produced by epithelia, fibroblasts, mast cells and adipocytes.
MMP-9, also known as collagenase type IV-B, is a predicted target of miR-212 and miR-132 (Miranda database). We tested this bioinformatic prediction using a luciferase assay approach. We cloned the 3′ UTR of MMP-9 downstream of the firefly luciferase gene and found that the normalized luciferase activity was substantially reduced upon cotransfection with either miR-212 or miR-132 or with both microRNAs together ('MMP-9' in Supplementary Fig. 8 ). However, this decrease in luciferase activity was abolished when the binding sites of miR-212 and miR-132 on the 3′ UTR of MMP-9 were mutated in the luciferase construct ('MMP-9-mut. ' in Supplementary Fig. 8 ). These results indicate that MMP-9 is a direct target of both miR-212 and miR-132.
Previous in situ hybridization data showed that MMP-9 is expressed at low levels throughout the mammary gland in the epithelia and stroma, but high levels of MMP-9 mRNA were also detected in some cells scattered within the fat pad 25 . We used immunohistochemistry to analyze MMP-9 expression in both wild-type and miR-212/132 −/− mammary glands.
In wild-type glands, we detected low levels of MMP-9 throughout the whole fat pad, with slightly higher levels in distal regions than in proximal regions. Around the TEBs, there were several fibroblasts in which MMP-9 was highly expressed (arrows in Fig. 7a) . We found low, diffuse staining in the periductal stroma of distal ducts; however, proximal ducts had almost no MMP-9 in their periductal stroma (Fig. 7b,c) . Some scattered cells in the fat pad had high MMP-9 levels (blue arrows in Fig. 7c) , consistent with the results of the in situ hybridization experiments 25 . By contrast, MMP-9 was much more A r t i c l e s highly expressed throughout the miR-212/132 −/− glands. All epithelial ducts contained high levels of diffuse MMP-9 staining in their periductal stroma (Fig. 7d-f ). In addition, we found fibroblasts that expressed MMP-9 in the periductal stroma of mutant ducts (black arrows in Fig. 7f ), similar to the fibroblasts observed around the neck region of TEBs in wild-type glands (Fig. 7a) . Also within the fatty stroma, there were many scattered cells, presumably fibroblasts, that contained high concentrations of MMP-9 (blue arrows in Fig. 7f ). These results indicate that in the absence of negative regulation by miR-212 and miR-132, the expression of MMP-9 in stromal cells is markedly increased. The accumulation of MMP-9 in the periductal stroma might explain the collagen deposition defect in miR-212/132 −/− glands.
Hyperactivation of TGF-b pathway in miR-212/132 −/− glands
TGF-β regulates ductal outgrowth and side branching during mammary gland development. 23, 24 Overexpression of TGF-β in pubertal mammary glands causes impairment of ductal outgrowth and results in simplified arborization patterns of ducts 23, 26 . All three isoforms of TGF-β are expressed in mammary epithelia with different spatiotemporal distributions 23, 26 . The TGF-β pathway suppresses the proliferation of epithelial cells and regulates the synthesis of ECM proteins by these cells. All three isoforms of TGF-β bind to the same TGF-β receptors and activate downstream pathways through the phosphorylation of Smad2 and Smad3 (ref. 27 ). However, TGF-β is secreted in a latent form as covalently associated with the latency-associated polypeptide (LAP) 23, 27 . Within the ECM, latent TGF-β-binding proteins (LTBPs) also bind to the LAP-TGF-β complexes to keep TGF-β in a latent state 27 . TGF-β accumulates in the periductal stroma within the mammary glands 23 . It is believed that the collagenrich ECM is important for maintaining a reservoir of latent TGF-β around the epithelial ducts and also for keeping TGF-β in a latent Figure 6 In the mammary gland, miR-212 and miR-132 are exclusively expressed in the stromal cells, but not in the epithelia. (a) Quantitative RT-PCR analyses were performed to detect the expression of miR-212 and miR-132 in 10-week-old whole mammary glands, cleared fat pads and stromal and epithelial organoid fractions from digested glands. Cleared fat pad samples, which are epithelium-free, have a three-fold higher expression of miR-212 and miR-132 than whole glands. Isolated stromal fractions from mammary glands have the highest expression of both miR-212 and miR-132, whereas isolated epithelial organoids express neither miR-212 nor miR-132. All expression levels were calculated as fold-changes compared to their levels in intact mammary glands from 10-week-old mice. (b) Quantitative RT-PCR analyses were performed for E-cadherin and vimentin to determine the presence of epithelial and fibroblast cells, respectively, in the same sample set as in a. The absence of E-cadherin expression in cleared fat pad and isolated stromal fraction samples proved that these samples were epithelium-free. The absence of vimentin expression in isolated epithelial organoids also showed that there was no fibroblast contamination in their preparation. Data are expressed as mean ± s.d.; n = 3 for each sample set. Immunohistochemical staining for MMP-9 (a-f) and phosphorylated Smad2 or 3 (p-Smad2/3; g-l) on mammary gland sections from 6-weekold wild-type mice (a-c, g-i) and homozygous mutant littermates (d-f, j-l). In wild-type mammary glands, high MMP-9 was seen only in the periductal stroma of TEBs. Arrows show the MMP-9-expressing fibroblasts in a. The periductal stroma of growth-quiescent ducts in wild-type glands has low MMP-9 staining (arrowheads in b and c). In the fat pad between ducts, there are a few scattered fibroblasts expressing high levels of MMP-9 (blue arrows in c). The periductal stroma in mutant glands shows high MMP-9 (arrowheads in d and e), and both periductal stroma and fat pad contain many MMP-9-expressing fibroblasts (black and blue arrows, respectively, in f). In wildtype mammary glands, p-Smad2/3 is present in the epithelial cells of TEBs and fibroblasts around TEBs (g). However, p-Smad2/3 is not detectable in the epithelia or stroma of growthquiescent ducts of wild-type glands (h,i). In mutant glands, most epithelial cells of all ducts are stained for p-Smad2/3 (j-l). There were also several p-Smad2/3-positive fibroblasts in both periductal stroma and fat pads of mutant glands (blue arrowheads in j-l). Scale bars represent 50 μm for h,i,k,l and 100 μm for other panels.
form by making it inaccessible to the proteins or environmental conditions that are necessary for its activation 23, 24 . MMP-9 can activate latent TGF-β by dissociating the latency complex that contains TGF-β, LAP and LTBPs 28, 29 . Therefore, high levels of MMP-9 and a marked reduction in collagen in the periductal stroma might result in the hyperactivation of latent TGF-β around the miR-212/132 −/− mammary ducts. To test this hypothesis, we performed immunohistochemical analyses with an antibody that recognizes only the phosphorylated forms of both Smad2 and Smad3. The presence of phosphorylated Smad2 or Smad3 in a cell is a strong indicator for the activation of the TGF-β pathway. In wild-type mammary glands, the majority of epithelia and fibroblasts in the proliferative zones, such as TEBs (Fig. 7g) and ductal side-buds (data not shown), were positive for phosphoSmad2 or phospho-Smad3. By contrast, in the growth-quiescent ductal regions of wild-type glands, almost no epithelia or fibroblasts showed detectable staining for phospho-Smad2 or phospho-Smad3 (Fig. 7h,i) . However, in miR-212/132 −/− glands, most of the epithelia in all ductal regions contained high levels of phospho-Smad2 or phospho-Smad3, indicating that the TGF-β pathway was highly active (Fig. 7j-l) . We also found several fibroblasts that contained phospho-Smad2 or phospho-Smad3 in the mutant stroma around the ducts (blue arrowheads in Fig. 7j-l) .
The main molecular pathway that is known to induce epithelial proliferation in pubertal mammary glands involves the transcriptional activation of the amphiregulin (Areg) gene by the estrogen receptor ERα in a manner that depends on the transcriptional cofactor Cited1 (ref. 11). TGF-β negatively regulates this pathway to suppress epithelial proliferation 11 . Therefore, we checked the levels of Cited1 and Areg mRNA in pubertal mammary glands and found that they were both significantly (P < 0.005) downregulated in miR-212/132 −/− glands (Supplementary Fig. 9 ). This provides additional evidence that the TGF-β pathway is hyperactivated in miR-212/132 −/− mammary glands.
To find out whether there is any deficiency of ERα expression in miR-212/132 −/− mammary glands, which might also cause the downregulation of Areg expression, we checked its expression pattern by imunohistochemistry (Supplementary Fig. 10 ). The expression of ERα in both epithelia and stroma of miR-212/132 −/− mammary glands was similar to that seen in wild-type glands. These results indicate that the downregulation of Areg mRNA in miR-212/132 −/− glands is not due to a defect in ERα expression, but might be due to the hyperactivation of the TGF-β pathway.
Together, our findings indicate that in the absence of miR-212 and miR-132, MMP-9 levels increase in the mutant mammary stroma, which probably causes the defect in collagen deposition and the hyperactivation of the TGF-β pathway. High TGF-β activity can downregulate Cited1 mRNA, thereby preventing the transcriptional activation of Areg in mammary epithelia, which in turn leads to impaired ductal outgrowth in miR-212/132 −/− mammary glands.
DISCUSSION
We have shown that the miR-212/132 family is required and indispensable for proper ductal outgrowth during pubertal development of the mammary glands in mice. Transplantation experiments showed that the impaired ductal outgrowth in miR-212/132 −/− mammary glands was caused by defects not in the epithelia but in the stroma. Levels of circulating estrogen and growth hormone were normal in miR-212/132 −/− mice. miR-212 and miR-132 were exclusively expressed by stromal cells in the mammary gland, and they directly downregulated the expression of MMP-9. In the absence of regulation by miR-212 and miR-132, MMP-9 increased and accumulated in the periductal stroma of mutant glands. The observed collagen deposition defects in miR-212/132 −/− glands were probably due to this increase in MMP-9. The periductal stroma accommodates a large reservoir of latent TGF-β, which is necessarily kept in an inactive state within the collagen-rich ECM 23 . As MMP-9 can activate latent TGF-β 28, 29 , the absence of collagen and high MMP-9 levels in mutant periductal stroma may eventually cause hyperactivation of latent TGF-β. Consistent with this model, we have shown that the TGF-β pathway was hyperactivated in miR-212/132 −/− mammary glands.
The TGF-β pathway positively regulates both the production and secretion of MMP-9 in various cell types [30] [31] [32] [33] [34] . Such possible upregulation of MMP-9 expression by TGF-β might generate a positive feedback loop in miR-212/132 −/− mammary glands, as MMP-9 can also activate the latent TGF-β 28, 29 . Therefore, the essential function of miR-212 and miR-132 might be to suppress this positive feedback loop, which otherwise might be deleterious for collagen-rich ECM formation around the mammary ducts and also might completely suppress ductal outgrowth.
Mice deficient in Cited1, Areg or Egfr (the receptor for amphiregulin) show impaired mammary ductal outgrowth phenotypes similar to that of miR-212/132 −/− mice [35] [36] [37] [38] . The downregulation of the expression of Cited1 and amphiregulin in miR-212/132 −/− glands might explain the similarity in the observed phenotypes. Cited1 also acts as a cofactor for Smad4 in the TGF-β pathway 39 . Therefore, high TGF-β activity in miR-212/132 −/− epithelia might selectively regulate the expression of a specific set of genes, whose regulation would not depend on the interaction between Cited1 and Smad4.
The signaling proteins Wnt5a and Fgfr2b are also downregulated in miR-212/132 −/− mammary glands (our unpublished microarray data). As Fgfr2b is essential for TEB maintenance 40, 41 , its downregulation might also explain the absence of TEBs in miR-212/132 −/− glands. Wnt5a is the main downstream mediator in the suppression of ductal outgrowth by TGF-β 42 . Its downregulation in miR-212/132 −/− glands might be explained by the possibility that its transcriptional control depends on the interaction between Smad4 and Cited1. However, in the absence of Wnt5a upregulation, ductal outgrowth is still impaired in miR-212/132 −/− glands, suggesting that other mediator(s) of the TGF-B pathway also regulate ductal outgrowth.
Previous studies showed the functional importance of other microRNAs in mammary epithelial cell lines [43] [44] [45] . However, our results provide the first in vivo example of microRNA function being required for mammary gland development. Moreover, we have shown that microRNAs not only regulate autonomous cell functions, but also are central to communication between stromal and epithelial cells.
URLs. Miranda database, http://www.microrna.org/.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Accession codes. The full-length sequence of primary transcript encoding the transcript variant 2 of miR-212/132 gene has been deposited in the GenBank database with the following accession number: HM627212.
in the target site of the seed regions of miR-212 and miR-132 by site-directed mutagenesis using the same 398-bp fragment and subsequently cloned into the same region in the pMIR-Report plasmid. The correct DNA sequences were confirmed by sequencing. The cloned constructs were cotransfected with miRNAs of interest (Ambion) and β-galactosidase control plasmid (Ambion) into HEK293 reporter cells seeded in 48-well plates using Lipofectamine2000 (Invitrogen). In each case, 0.2 μg plasmid DNA, 100 nM miRNA and 0.5 μl Lipofectamine2000 were applied. Cells were incubated for 24 h before luciferase and β-galactosidase activity were measured using the Luciferase Assay System (Promega) and Beta-Galactosidase Assay system (Promega) kits on a multi-plate reader (Biotek, Synergy HT) according to the manufacturers´ instructions.
Statistics. Data are expressed as mean ± s.d. or as median ± s.e.m. Statistical comparisons were tested by Student's t-test using Graphpad Prism software. P < 0.05 was considered statistically significant.
